DeepMind spinout Isomorphic Labs in talks to raise funds at $40B–$50B valuation: report
- Isomorphic Labs, an AI-powered drug discovery startup spun out of Alphabet Inc.’s Google DeepMind (GOOG) (GOOG), is in early talks to raise new funds at a valuation of at least $40B, according to Bloomberg.
- The round could value Isomorphic as highly as $50B, one of the sources said. The financing hasn’t closed, and details could change, as per the report.
- Only five months ago, Isomorphic Labs raised $2.1B in its Series B funding effort.
- Separately, the US government and tech giants Meta Platforms (META) and Google parent Alphabet are joining nonprofit Biohub to build open datasets to train AI models for biological reasearch, bringing total investment in the effort to $1.8B, Biohub said on Wednesday.
- Meta, Google DeepMind and drug discovery startup Isomorphic Labs are jointly investing $300M.
Recommended For You
Register for free to keep reading.
Create a free account to get unlimited breaking news and alerts when your stocks move.
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.